About our research
In the research group we use data from the Swedish MS register sometimes also linked to data from Swedish public databases such as the National Board of Health and Welfare (Socialstyrelsen), Statistics Sweden (SCB) and the Swedish Social Insurance Agency (Försäkringskassan).
Using this type of “real-world data”, we want to describe disease progression, treatment methods and socio-economic outcomes in MS patients. Our hope is that our studies will contribute to increased knowledge about factors that affect MS disease with the ambition to ultimately create improved and cost-effective health care for MS patients.
The research group includes molecular biologists, statisticians and neurologists.
Research Projects
- MS clinical course
Description and analysis of MS disease progression. Studies of different factors influencing disease progression.
- Treatment studies
Safety and efficacy studies.
- Health economic consequences of MS
Costs of MS, sick leave, disability pension, income.
Anna Glaser's research group